Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells

Nature Immunology

Volumn 14, Issue 9, 2013, Pages 908-916

  Vavassori, Stefano ^a   Kumar, Anil ^b   Wan, Gan Siok ^b   Ramanjaneyulu, Gundimeda S ^a   Cavallari, Marco ^a   El Daker, Sary ^b   Beddoe, Travis ^c   Theodossis, Alex ^c   Williams, Neal K ^c   Gostick, Emma ^d   Price, David A ^d   Soudamini, Dinish U ^e   Voon, Kong Kien ^e   Olivo, Malini ^e   Rossjohn, Jamie ^c,d   Mori, Lucia ^a,b   De Libero, Gennaro ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b AGENCY FOR SCIENCE   (Singapore)

^c MONASH UNIVERSITY   (Australia)

^d CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^e AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYROPHILIN 3A1; CD1 ANTIGEN; CELL PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MULTIPROTEIN COMPLEX; PRENYLAMINE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; ARTICLE; BINDING AFFINITY; CHROMOSOME 6; CONTROLLED STUDY; GAMMA DELTA T LYMPHOCYTE; GENE EXPRESSION; GENETIC IDENTIFICATION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; STOICHIOMETRY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENICS;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS; ANTIGENS, CD; CHROMOSOMES, HUMAN, PAIR 6; HUMANS; MICE; MICE, TRANSGENIC; MODELS, MOLECULAR; ORGANOPHOSPHATES; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS;

EID: 84883147590     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2665     Document Type: Article

References (50)

1. Tanaka, Y., Morita, C.T., Nieves, E., Brenner, M.B. & Bloom, B.R. Natural and synthetic non-peptide antigens recognized by human T cells. Nature 375, 155-158 (1995).
2. Burk, M.R., Mori, L. & De Libero, G. Human V9-V2 cells are stimulated in a cross-reactive fashion by a variety of phosphorylated metabolites. Eur. J. Immunol. 25, 2052-2058 (1995).
3. Hintz, M. et al. Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human T cells in Escherichia coli. FEBS Lett. 509, 317-322 (2001).
4. Lange, B.M., Rujan, T., Martin, W. & Croteau, R. Isoprenoid biosynthesis: the evolution of two ancient and distinct pathways across genomes. Proc. Natl. Acad. Sci. USA 97, 13172-13177 (2000).
5. Morita, C.T., Jin, C., Sarikonda, G. & Wang, H. Nonpeptide antigens, presentation mechanisms, and immunological memory of human V?2V?2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol. Rev. 215, 59-76 (2007).
6. Gober, H.J. et al. Human T cell receptor cells recognize endogenous mevalonate metabolites in tumor cells. J. Exp. Med. 197, 163-168 (2003).
7. Wang, H. et al. Conservation of nonpeptide antigen recognition by rhesus monkey V?2V?2 T cells. J. Immunol. 170, 3696-3706 (2003).
8. De Libero, G. et al. Selection by two powerful antigens may account for the presence of the major population of human peripheral ?/T cells. J. Exp. Med. 173, 1311-1322 (1991).
9. Morita, C.T. et al. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human T cells. Immunity 3, 495-507 (1995).
10. Lang, F. et al. Early activation of human V9V2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands. J. Immunol. 154, 5986-5994 (1995).
11. Allison, T.J., Winter, C.C., Fournie, J.J., Bonneville, M. & Garboczi, D.N. Structure of a human T-cell antigen receptor. Nature 411, 820-824 (2001).
12. Wang, H., Fang, Z. & Morita, C.T. V2V2 T cell receptor recognition of prenyl pyrophosphates is dependent on all CDRs. J. Immunol. 184, 6209-6222 (2010).
13. Kato, Y., Tanaka, Y., Tanaka, H., Yamashita, S. & Minato, N. Requirement of species-specific interactions for the activation of human T cells by pamidronate. J. Immunol. 170, 3608-3613 (2003).
14. Green, A.E. et al. Recognition of nonpeptide antigens by human V9V2 T cells requires contact with cells of human origin. Clin. Exp. Immunol. 136, 472-482 (2004).
15. Trent, J.M., Thompson, F.H. & Meyskens, F.L. Jr. Identification of a recurring translocation site involving chromosome 6 in human malignant melanoma. Cancer Res. 49, 420-423 (1989).
16. Pappas, G.J., Polymeropoulos, M.H., Boyle, J.M. & Trent, J.M. Regional assignment by hybrid mapping of 36 expressed sequence tags (ESTs) on human chromosome 6. Genomics 25, 124-129 (1995).
17. Goodfellow, P.N., Banting, G., Trowsdale, J., Chambers, S. & Solomon, E. Introduction of a human X-6 translocation chromosome into a mouse teratocarcinoma: investigation of control of HLA-A, B, C expression. Proc. Natl. Acad. Sci. USA 79, 1190-1194 (1982).
18. Sakaguchi, A.Y. et al. Regional localization of two human cellular Kirsten ras genes on chromosomes 6 and 12. Mol. Cell. Biol. 4, 989-993 (1984).
19. Orphanos, V. et al. A radiation hybrid panel for human chromosome 6q. Mamm. Genome 6, 285-290 (1995).
20. Bas, A. et al. Butyrophilin-like 1 encodes an enterocyte protein that selectively regulates functional interactions with T lymphocytes. Proc. Natl. Acad. Sci. USA 108, 4376-4381 (2011).
21. Messal, N. et al. Differential role for CD277 as a co-regulator of the immune signal in T and NK cells. Eur. J. Immunol. 41, 3443-3454 (2011).
22. Boyden, L.M. et al. Skint1, the prototype of a newly identified immunoglobulin superfamily gene cluster, positively selects epidermal T cells. Nat. Genet. 40, 656-662 (2008).
23. Harly, C. et al. Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human T-cell subset. Blood 120, 2269-2279 (2012).
24. Sarikonda, G. et al. Photoaffinity antigens for human T cells. J. Immunol. 181, 7738-7750 (2008).
25. Ernst, W.A. et al. Molecular interaction of CD1b with lipoglycan antigens. Immunity 8, 331-340 (1998).
26. Naidenko, O.V. et al. Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules. J. Exp. Med. 190, 1069-1080 (1999).
27. Khilko, S.N. et al. Measuring interactions of MHC class I molecules using surface plasmon resonance. J. Immunol. Methods 183, 77-94 (1995).
28. Clements, C.S. et al. The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis. Proc. Natl. Acad. Sci. USA 100, 11059-11064 (2003).
29. Stamper, C.C. et al. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature 410, 608-611 (2001).
30. Schwartz, J.C., Zhang, X., Fedorov, A.A., Nathenson, S.G. & Almo, S.C. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex. Nature 410, 604-608 (2001).
31. Palakodeti, A. et al. The molecular basis for modulation of human V9V2 T cell responses by CD277/butyrophilin-3 (BTN3A)-specific antibodies. J. Biol. Chem. 287, 32780-32790 (2012).
32. Adams, E.J. & Luoma, A.M. The adaptable major histocompatibility complex (MHC) fold: structure and function of nonclassical and MHC class I-like molecules. Annu. Rev. Immunol. 31, 529-561 (2013).
33. Kjer-Nielsen, L. et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491, 717-723 (2012).
34. Belmant, C. et al. A chemical basis for selective recognition of nonpeptide antigens by human T cells. FASEB J. 14, 1669-1670 (2000).
35. Morita, C.T. et al. Structural features of nonpeptide prenyl pyrophosphates that determine their antigenicity for human T cells. J. Immunol. 167, 36-41 (2001).
36. Reichenberg, A. et al. Replacing the pyrophosphate group of HMB-PP by a diphosphonate function abrogates Its potential to activate human T cells but does not lead to competitive antagonism. Bioorg. Med. Chem. Lett. 13, 1257-1260 (2003).
37. Li, Y. et al. Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule. EMBO J. 24, 2968-2979 (2005).
38. Nie, S. & Emory, S.R. Probing single molecules and single nanoparticles by surface-enhanced Raman scattering. Science 275, 1102-1106 (1997).
39. Kho, K.W., Dinish, U.S., Kumar, A. & Olivo, M. Frequency shift in SERS for biosensing. ACS Nano 6, 4892-4902 (2012).
40. Compte, E., Pontarotti, P., Collette, Y., Lopez, M. & Olive, D. Frontline: Characterization of BT3 molecules belonging to the B7 family expressed on immune cells. Eur. J. Immunol. 34, 2089-2099 (2004).
41. Yamashiro, H., Yoshizaki, S., Tadaki, T., Egawa, K. & Seo, N. Stimulation of human butyrophilin 3 molecules results in negative regulation of cellular immunity. J. Leukoc. Biol. 88, 757-767 (2010).
42. Smith, I.A. et al. BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activation. J. Immunol. 184, 3514-3525 (2010).
43. Cella, M., Engering, A., Pinet, V., Pieters, J. & Lanzavecchia, A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388, 782-787 (1997).
44. Shamshiev, A. et al. Presentation of the same glycolipid by different CD1 molecules. J. Exp. Med. 195, 1013-1021 (2002).
45. Hayday, A.C. cells: a right time and a right place for a conserved third way of protection. Annu. Rev. Immunol. 18, 975-1026 (2000).
46. Carena, I., Shamshiev, A., Donda, A., Colonna, M. & Libero, G.D. Major histocompatibility complex class I molecules modulate activation threshold and early signaling of T cell antigen receptor-?/? stimulated by nonpeptidic ligands. J. Exp. Med. 186, 1769-1774 (1997).
47. Halary, F. et al. Control of self-reactive cytotoxic T lymphocytes expressing T cell receptors by natural killer inhibitory receptors. Eur. J. Immunol. 27, 2812-2821 (1997).
48. Pennington, D.J. et al. The integration of conventional and unconventional T cells that characterizes cell-mediated responses. Adv. Immunol. 87, 27-59 (2005).
49. Kistowska, M. et al. Dysregulation of the host mevalonate pathway during early bacterial infection activates human TCR cells. Eur. J. Immunol. 38, 2200-2209 (2008).
50. Kabelitz, D., Wesch, D. & He, W. Perspectives of T cells in tumor immunology. Cancer Res. 67, 5-8 (2007).